← Leaderboards
Constance L Cepko
Harvard Medical School
$19,977,994
Attributed
$24,125,827
Total exposure
12
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.5M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$24,125,827 · 12
By mechanism
R01$17,284,803 · 8
U01$5,249,355 · 1
R21$886,383 · 2
T32$705,286 · 1
Top collaborators
- Florian Engert3 shared
- Jeff W Lichtman3 shared
- Haim Sompolinsky3 shared
- Robert J Vassar2 shared
Most similar at Harvard Medical School
Same institution · by research overlap
- Ryan Delgado$247,234
- Mark M Emerson$3,480,901
- Elliott Scott Milner$94,788
Others in their field
Top investigators on “Retina”
- Keri Hammel · The Emmes Company, Llc$53,700,408
- Krzysztof Palczewski · University Of California-Irvine$48,214,939
- Adam R Glassman · Jaeb Center For Health Research, Inc.$47,242,041
- Cecilia Sungmin Lee · University Of Washington$32,086,169
- Adam Glassman · Jaeb Center For Health Research, Inc.$31,583,813
- Karen J Cruickshanks · University Of Wisconsin Madison$28,499,261
Research focus
RetinaCell TypeGene ExpressionGenesCellsRetinal ConePhotoreceptorsTranscription FactorAreaLaboratory MouseLeadGeneticNeuronsMapsMediatingBlindnessComplexStem CellsViralVirusProductionPatternImmunocytochemistryBase
Grant awards (58)
The Role of Lineage in Development of Chicken Retina and High Acuity Area$464,750
R21 · FY2025 · EY · contact PI
Determination of Cone Photoreceptor Fate$416,635
R01 · FY2023 · EY · contact PI
AAV Induced Toxicity in the Eye$416,375
R01 · FY2023 · EY · contact PI
AAV Induced Toxicity in the Eye$405,953
R01 · FY2022 · EY · contact PI
Determination of Cone Photoreceptor Fate$404,135
R01 · FY2022 · EY · contact PI
Determination of Cone Photoreceptor Fate$404,135
R01 · FY2021 · EY · contact PI
AAV Induced Toxicity in the Eye$403,883
R01 · FY2021 · EY · contact PI
Determination of Cone Photoreceptor Fate$416,635
R01 · FY2020 · EY · contact PI
AAV Induced Toxicity in the Eye$416,375
R01 · FY2020 · EY · contact PI
AAV Induced Toxicity in the Eye$418,508
R01 · FY2019 · EY · contact PI
Determination of Cone Photoreceptor Fate$416,635
R01 · FY2019 · EY · contact PI
Gene Therapy for Alzheimer's Disease$181,198
R21 · FY2019 · AG · contact PI
Gene Therapy for Alzheimer's Disease$240,435
R21 · FY2018 · AG · contact PI
Development of novel transsynaptic tracers for use in the central nervous system$365,020
R01 · FY2017 · NS · contact PI
Neural circuits in zebrafish: form, function and plasticity$1,767,954
U01 · FY2016 · NS
Development of novel transsynaptic tracers for use in the central nervous system$368,957
R01 · FY2016 · NS · contact PI
Neural circuits in zebrafish: form, function and plasticity$1,745,025
U01 · FY2015 · NS
Gene therapy to support cone metabolism in retinitis pigmentosa$415,275
R01 · FY2015 · EY · contact PI
Development of novel transsynaptic tracers for use in the central nervous system$368,957
R01 · FY2015 · NS · contact PI
Neural circuits in zebrafish: form, function and plasticity$1,736,376
U01 · FY2014 · NS
Gene therapy to support cone metabolism in retinitis pigmentosa$415,275
R01 · FY2014 · EY · contact PI
Development of novel transsynaptic tracers for use in the central nervous system$367,074
R01 · FY2014 · NS · contact PI
Gene therapy to support cone metabolism in retinitis pigmentosa$423,334
R01 · FY2013 · EY · contact PI
Molecular Biology of Retinal Development$380,846
R01 · FY2013 · EY · contact PI
Development of novel transsynaptic tracers for use in the central nervous system$370,781
R01 · FY2013 · NS · contact PI
Molecular Biology of Retinal Development$401,063
R01 · FY2012 · EY · contact PI
Molecular Biology of Retinal Development$401,230
R01 · FY2011 · EY · contact PI
Molecular Biology of Retinal Development$413,937
R01 · FY2010 · EY · contact PI
Determination of Retinal Cell Fate$412,035
R01 · FY2010 · EY · contact PI
Determination of Retinal Cell Fate$417,888
R01 · FY2009 · EY · contact PI
Molecular Biology of Retinal Development$417,575
R01 · FY2009 · EY · contact PI
Determination of Retinal Cell Fate$418,360
R01 · FY2008 · EY · contact PI
Cell fate determination in the retina$370,329
R01 · FY2007 · EY · contact PI
Gene Expression Profiles of Retinal Degeneration$288,033
R01 · FY2007 · EY · contact PI
Molecular Biology of Retinal Development$390,656
R01 · FY2006 · EY · contact PI
Cell fate determination in the retina$372,414
R01 · FY2006 · EY · contact PI
Gene Expression Profiles of Retinal Degeneration$289,655
R01 · FY2006 · EY · contact PI
Cell fate determination in the retina$381,375
R01 · FY2005 · EY
Molecular Biology of Retinal Development$339,000
R01 · FY2005 · EY
Gene Expression Profiles of Retinal Degeneration$296,625
R01 · FY2005 · EY
Cell fate determination in the retina$381,375
R01 · FY2004 · EY
Molecular Biology of Retinal Development$339,000
R01 · FY2004 · EY
Gene Expression Profiles of Retinal Degeneration$295,313
R01 · FY2004 · EY
Cell fate determination in the retina$378,000
R01 · FY2003 · EY
Molecular Biology of Retinal Development$336,500
R01 · FY2003 · EY
Gene Expression Profiles of Retinal Degeneration$302,000
R01 · FY2003 · EY
Research Training in Molecular Approaches to Vision$237,169
T32 · FY2003 · EY
DETERMINATION OF RETINAL CELL FATE$263,377
R01 · FY2002 · EY
MOLECULAR BIOLOGY OF RETINAL DEVELOPMENT$227,915
R01 · FY2002 · EY
RESEARCH TRAINING IN MOLECULAR APPROACHES TO VISION$196,259
T32 · FY2002 · EY
GENE EXPRESSION IN SINGLE, IDENTIFIED CNS CELLS$345,280
R01 · FY2001 · EY
DETERMINATION OF RETINAL CELL FATE$255,706
R01 · FY2001 · EY
MOLECULAR BIOLOGY OF RETINAL DEVELOPMENT$161,654
R01 · FY2001 · EY
RESEARCH TRAINING IN MOLECULAR APPROACHES TO VISION$136,131
T32 · FY2001 · EY
GENE EXPRESSION IN SINGLE, IDENTIFIED CNS CELLS$335,223
R01 · FY2000 · EY
DETERMINATION OF RETINAL CELL FATE$248,258
R01 · FY2000 · EY
MOLECULAR BIOLOGY OF RETINAL DEVELOPMENT$210,239
R01 · FY2000 · EY
RESEARCH TRAINING IN MOLECULAR APPROACHES TO VISION$135,727
T32 · FY2000 · EY